BlueCrest Capital Management’s Ingevity NGVT Stock Holding History

BlueCrest Capital Management’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,169	Closed	-$335K	–	835
2019 Q1	$335K	Buy	+3,169	New	+$318K	0.01%	648
2018 Q4	–	Sell	-2,168	Closed	-$221K	–	1231
2018 Q3	$221K	Buy	+2,168	New	+$209K	0.01%	1219
2017 Q4	–	Sell	-18,135	Closed	-$1.13M	–	1008
2017 Q3	$1.13M	Buy	+18,135	New	+$1.07M	0.05%	356
2017 Q1	–	Sell	-26,868	Closed	-$1.47M	–	890
2016 Q4	$1.47M	Buy	+26,868	New	+$1.29M	0.08%	304

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlueCrest Capital Management's NGVT Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Ingevity (NGVT) in Q2 2019, closing a stake of 3,169 shares — an estimated $335K sold.

BlueCrest Capital Management first reported a position in NGVT in Q4 2016 and held it in 4 quarters. The position peaked at $1.47M in Q4 2016. 334 funds tracked by Wall St. Rank hold NGVT as of Q2 2019.

BlueCrest Capital Management reported no remaining Ingevity position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 3,169 Ingevity shares in Q2 2019, an estimated $335K.
BlueCrest Capital Management first reported a position in Ingevity in Q4 2016 and held it in 4 quarters.
BlueCrest Capital Management's Ingevity position peaked at $1.47M in Q4 2016.
334 funds tracked by Wall St. Rank held Ingevity as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.